Literature DB >> 12209086

Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma.

Ting-Fan Leung1, Chun-Kwok Wong, Iris H S Chan, Wai-Ki Ip, Christopher W K Lam, Gary W K Wong.   

Abstract

BACKGROUND: Thymus and activation-regulated chemokine (TARC) is responsible for the trafficking of T(H)2 lymphocytes into sites of allergic inflammation. Serum TARC levels correlate with the severity of atopic dermatitis. The relationship between this marker and the occurrence and severity of asthma has not been evaluated.
OBJECTIVE: We tested whether plasma TARC level is a useful marker for asthma and atopy in children.
METHODS: Plasma total IgE levels were measured by means of microparticle immunoassay, and specific IgE levels to common aeroallergens were measured by using a fluorescent enzyme immunoassay. We used a sandwich enzyme immunoassay to measure plasma TARC concentrations.
RESULTS: Sixty asthmatic children and 28 age- and sex-matched control subjects were recruited, with mean logarithmic plasma total IgE levels of 2.66 +/- 0.60 kIU/L and 1.74 +/- 0.58 kIU/L, respectively (P <.0001). The median plasma TARC concentration was higher in asthmatic patients without inhaled corticosteroid treatment (131.0 pg/mL) compared with those seen in steroid-treated patients (97.5 pg/mL) and control subjects (76.0 pg/mL; P =.01 and P <.0001, respectively). Plasma TARC concentration was found to correlate with total IgE level in plasma (r = 0.219, P =.04). This marker was also increased in subjects who were sensitized to cat allergen (P =.001) but not in subjects sensitized to other aeroallergens. Disease severity score, FEV(1) value, and atopy were not associated with increased plasma TARC levels.
CONCLUSION: Our results suggest that plasma TARC concentrations are elevated in childhood asthma. This marker is also linked to plasma total IgE levels and cat allergen sensitization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209086     DOI: 10.1067/mai.2002.126378

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  26 in total

1.  Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study.

Authors:  Bart van Hartingsveldt; Ivo P Nnane; Esther Bouman-Thio; Matthew J Loza; Alexa Piantone; Hugh M Davis; Kevin J Petty
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

2.  T-helper type 2 polarization among asthmatics during and following pregnancy.

Authors:  D Rastogi; C Wang; C Lendor; P B Rothman; R L Miller
Journal:  Clin Exp Allergy       Date:  2006-07       Impact factor: 5.018

3.  Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.

Authors:  C K Wong; S W M Lun; F W S Ko; W K Ip; D S C Hui; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

4.  Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis.

Authors:  T F Leung; G W K Wong; F W S Ko; C W K Lam; T F Fok
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

5.  Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells.

Authors:  C K Wong; C B Wang; W K Ip; Y P Tian; C W K Lam
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

6.  The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity.

Authors:  Gregory S Whitehead; Tie Wang; Laura M DeGraff; Jeffrey W Card; Sergio A Lira; Gerard J Graham; Donald N Cook
Journal:  Am J Respir Crit Care Med       Date:  2006-11-09       Impact factor: 21.405

Review 7.  Personalised medicine and asthma diagnostics/management.

Authors:  Samuel J Wadsworth; Andrew J Sandford
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 8.  Which biomarkers are effective for identifying Th2-driven inflammation in asthma?

Authors:  Zuzana Diamant; Ellen Tufvesson; Leif Bjermer
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

9.  Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells.

Authors:  Anne McIlroy; Gersende Caron; Simon Blanchard; Isabelle Frémaux; Dorothée Duluc; Yves Delneste; Alain Chevailler; Pascale Jeannin
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

10.  Interleukin-31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen-activated protein kinase signalling pathways: implications for the allergic response.

Authors:  Wai K Ip; Chun K Wong; Mandy L Y Li; Pok W Li; Phyllis F Y Cheung; Christopher W K Lam
Journal:  Immunology       Date:  2007-07-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.